THYMOSIN ALPHA 1
STUDIES & RESEARCH
Our Medical Team is constantly engaging in research and development, and keeping up to date with the latest medical papers and clinical trials to inform our patients about the peptides we supply. Access the latest clinical studies relating to Thymosin Alpha 1 below.
Thymosin Alpha-1 is taken through subcutaneous injection and is a powerful modulator of immunity and inflammation. This 28 amino acid Peptide has been widely studied as an immunity booster in conjunction with flu vaccinations. Thymosin Alpha-1 works to enhance T cell function and antibody responses.
